Case Study: Fortune 500 Biotechnology Company strengthens continuous security validation across IT and OT with SafeBreach

Fortune 500 Biotechnology Company Establishes Continuous Security Validation across IT & OT Environments with SafeBreach

A Fortune 500 Biotechnology Company turned to SafeBreach when the shift to remote and hybrid work during COVID-19 made it difficult to ensure its security controls were truly protecting employees across both IT and OT environments. The company needed to move beyond point-in-time validation methods like penetration testing and manual reviews, and instead gain continuous visibility into how well its controls could defend against evolving threats targeting remote workers.

Using SafeBreach Validate and SafeBreach-as-a-Service, the company deployed more than 50 simulators, built 28 integrations, and established a monthly attack-simulation cadence across IT and OT. SafeBreach helped quantify control effectiveness, improve detection of US-CERT and FBI Flash-related threats, and support remediation through dashboards and Insights, while also enabling a data-driven EDR vendor evaluation that uncovered and corrected a critical misconfiguration.